chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.25
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Febrile convulsion
Clinical narrative: Febrile Seizures on the evening following the vaccine. Taken to emergency room and stabilized. The patient has since recovered from the event.
Age: 19.0
Sex: F
Vaccine: VARCEL
Symptoms: Juvenile idiopathic arthritis, Polymerase chain reaction positive, Rash, Varicella post vaccine, Varicella virus test positive
Clinical narrative: Telephone memo has been received from a physician confirming that a specimen has been collected and submitted to the Varicella Zoster Virus Identification Program (VZVIP) program: "the female patient (age and ethnicity were unknown) enrolled in the VZVIP to identify if VZV is present and if it is present, to identify if it is associated with the wild-type (WT) VZV strain or with the OKA/Merck vaccine strain". The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with VARIVAX (dose, frequency, route and lot# not specified) as prophylaxis. On an unknown date, the patient had juvenile idiopathic arthritis (JIA), and was receiving the "newest biologics" (product name not specified). And whenever she got the biologics, she developed a rash reported as VZV on whatever side she received the biologic. A sample was obtained with this occurrence and was found to be polymerase chain reaction (PCR) positive for VZV in the hospital lab. The patient was hospitalized. The lab was not open over the weekend and was asked to hold the sample for shipment until Monday (18-SEP-2017). On that day, the physician was contacted. The physician confirmed that she would not be sending the sample on that day. The site would speak with the physician regarding the paperwork and submitting the sample. The outcome of all the events was not reported. The causality between all the events and VARIVAX was not reported. Upon internal review, the event of juvenile idiopathic arthritis (JIA) was considered to be medically significant. Follow up information was received on 21-SEP-2017. It was confirmed that the sample sent on 20-SEP-2017 from the VZVIP Laboratory was received on 21-SEP-2017. Company Causality Assessment: Based on the limited information currently available for this case, a reasonable possibility to suggest a relationship between the VARIVAX vaccine and the reported events of varicella zoster virus infection and juvenile idiopathic arthritis cannot be established. The report doesn't include medical history, concurrent conditions, exposure to someone with varicella, concomitant medications. Additionally the report also does not provide time to onset (No dates of Vaccine administration, neither start date of the event). Company Comment- No changes to the product safety information are warranted at this time. Merck and Co., Inc., also known as MSD, continues to monitor the safety profile of the product.
Sex: F
Vaccine: PPV
Symptoms: Flushing, Peripheral swelling, Skin exfoliation
Clinical narrative: This spontaneous report has been received from a pharmacist referring to an approximately 72 year old female patient. The patient did not have drug reactions or allergies history. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported. In approximately 2009 (reported as "7 or 8 years ago"), the patient was vaccinated with PNEUMOVAX 23 (strength, dose, route, lot number and expiration date was not reported) for prophylaxis. Right after vaccination, when the patient walked out of the doctor's office, she got all flushed and her hands started to swell and then the skin on her hands started to peel off. The patient was seen by an unspecified health care provider "at that time of the incident" and no treatment was given. The reporter mentioned that the patient was fine now but he did not know when she recovered. At the reporting time the causality assessment between PNEUMOVAX 23 and the events was not reported.
Age: 0.17
Sex: U
Vaccine: RV5
Symptoms: Diarrhoea haemorrhagic
Clinical narrative: This spontaneous report was received from a physician, and refers to a 2 month old patient of unknown gender. No information about the patient's medical history, concurrent conditions or concomitant medications was provided. On an unspecified date in 2017 (reported as recently), the patient was vaccinated with a dose of ROTATEQ, orally, for vaccination, (dose, frequency, lot number and expiration date were not provided). On an unspecified date in 2017 (reported as at an unknown point in time after receiving the dose),  the patient began to experience bloody diarrhea. The patient sought for medical attention on an unspecified date. No product quality complaint (PQC) was involved. The outcome of diarrhoea hemorrhagic was reported as not recovered. The causal relationship between ROTATEQ and diarrhoea hemorrhagic was not provided. Upon internal review, the event diarrhoea hemorrhagic was determined to be a medically significant event.
Sex: F
Vaccine: HPV9
Symptoms: Burning sensation, Fatigue, Gait disturbance, Limb discomfort, Loss of personal independence in daily activities
Clinical narrative: This spontaneous report has been received from a licensed practical nurse referring to a 18 year old female patient. The patient did not have pertinent medical history, drug reactions or allergies or concurrent conditions. Concomitant therapies included LYRICA. On 28-JUN-2016, the patient was vaccinated with the first dose of GARDASIL 9 lot # M007728, expiration date 21-MAR-2018 (strength, dose, route and anatomical location were not provided) for prophylaxis. On 15-AUG-2016, the patient received the second dose of GARDASIL 9 lot # M004116, expiration date 12-OCT-2017. Later on 06-JAN-2017, the patient received the third dose of GARDASIL 9 lot # M031557, expiration date 07-APR-2019. The 3 doses were given for prevention of human papilloma virus (HPV). It was reported that on an unspecified dates in 2017 (reported as after the administration of GARDASIL 9 on 06-JAN-2017), the patient began experience "strep throat, sore throats and red throats"; "aches" and fatigue, then the patient developed right lower extremity pain and "limb discomfort" that prevented the patient from "walking and exercising" and "burning in both feet at night". The reporter stated that the patient had been to multiple unspecified doctors including an "autoimmune doctor" who gave her unspecified treatments. On an unknown date in 2017, the patient was prescribed an unspecified antibiotic for "ear, nose and throat" from an unspecified physician. The patient was scheduled for an appointment with physician on 22-SEP-2017. At the reporting time, the outcome of the patient and the causality assessment between therapy with GARDASIL 9 and the events were not reported.
Sex: F
Vaccine: HPV9
Symptoms: Oropharyngeal pain, Pain, Pain in extremity, Pharyngeal erythema, Pharyngitis streptococcal
Clinical narrative: This spontaneous report has been received from a licensed practical nurse referring to a 18 year old female patient. The patient did not have pertinent medical history, drug reactions or allergies or concurrent conditions. Concomitant therapies included LYRICA. On 28-JUN-2016, the patient was vaccinated with the first dose of GARDASIL 9 lot # M007728, expiration date 21-MAR-2018 (strength, dose, route and anatomical location were not provided) for prophylaxis. On 15-AUG-2016, the patient received the second dose of GARDASIL 9 lot # M004116, expiration date 12-OCT-2017. Later on 06-JAN-2017, the patient received the third dose of GARDASIL 9 lot # M031557, expiration date 07-APR-2019. The 3 doses were given for prevention of human papilloma virus (HPV). It was reported that on an unspecified dates in 2017 (reported as after the administration of GARDASIL 9 on 06-JAN-2017), the patient began experience "strep throat, sore throats and red throats"; "aches" and fatigue, then the patient developed right lower extremity pain and "limb discomfort" that prevented the patient from "walking and exercising" and "burning in both feet at night". The reporter stated that the patient had been to multiple unspecified doctors including an "autoimmune doctor" who gave her unspecified treatments. On an unknown date in 2017, the patient was prescribed an unspecified antibiotic for "ear, nose and throat" from an unspecified physician. The patient was scheduled for an appointment with physician on 22-SEP-2017. At the reporting time, the outcome of the patient and the causality assessment between therapy with GARDASIL 9 and the events were not reported.
Sex: U
Vaccine: HEP
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a registered nurse, and refers to multiple unspecified patients of unknown age and gender. The patients' current conditions, medical history and concomitant medications were not reported. On multiple unspecified dates, the patients received improperly stored doses of RECOMBIVAX HB, lot number M036156, expiration date 23-FEB-2019, for prophylaxis (routes of administration were not provided). On unknown dates, the doses of RECOMBIVAX HB underwent temperature excursions of 9 degrees Celsius (°C) to 25°C for a time frame of 1 hour and 9°C to 25°C for 10 minutes, which were detected by the data logger. No adverse effects were reported. This is one of several cases received from the same reporter. Sender's Comments: US-009507513-1709USA010721: US-009507513-1709USA012219: US-009507513-1709USA010721: US-009507513-1709USA012222.
Sex: U
Vaccine: HEPA
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a registered nurse, and refers to multiple unspecified patients of unknown age and gender. The patients' current conditions, medical history and concomitant medications were not reported. On multiple unspecified dates, the patients received improperly stored doses of VAQTA, lot number M047658, expiration date 28-OCT-2017, for prophylaxis (routes of administration were not provided). On unknown dates, the doses of VAQTA underwent temperature excursions of 9 degrees Celsius (°C) to 25°C for a time frame of 1 hour and 9°C to 25°C for 10 minutes, which were detected by the data logger. No adverse effects were reported. This is one of several cases received from the same reporter. Sender's Comments: US-009507513-1709USA010721: US-009507513-1709USA012219: US-009507513-1709USA012220: US-009507513-1709USA012221.
Sex: U
Vaccine: HIBV, HPV9
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report has been received from a nurse referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug, allergy history or concomitant medications. On an unknown date, the patient was vaccinated with improperly stored doses GARDASIL 9 lot # M041990 with expiration date 28-JUN-2019, lot# N004799 with expiration date 25-NOV-2019, lot# M042853 with expiration date 27-JUL-2019, or lot# N013276 with expiration date 21-JAN-2020, (strength, dose and route of administration were not provided) for prophylaxis. Other suspect therapies included improperly stored doses of PEDVAXHIB, lot # N007751 with expiration date 30-NOV-2019, lot # N000238 with expiration date 25-OCT-2019, or lot # N003537 with expiration date 17-NOV-2019 (strength, dose and route of administration  were not provided) for prophylaxis. The reporter stated that she was not sure which lot the patient received. The doses of GARDASIL 9 and PEDVAXHIB were exposed to a temperature of 29 Fahrenheit (°F) during a time frame of 63 hours and 15 minutes, which was not detected by the data logger. There was no previous temperature excursion. No adverse effects were reported.
Sex: U
Vaccine: HPV9
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a registered nurse, concerning multiple unspecified patients of an unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On an unspecified date, the patients were vaccinated with improperly stored doses GARDASIL 9 with lot # reported as N019523 and expiration date on 28-APR-2019 (strength, dose, route of administration or anatomical location were not reported), administered for prophylaxis. The storage temperature was 9 to 25 degrees Celsius (°C) (9.8 °C), for a timeframe of 20 minutes and 9 to 25 °C (8.5 °C) for 7 minutes. There was previous temperature excursion at 9 to 25 °C for 3.31 hours. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA015078: US-009507513-1709USA015077.
Age: 23.0
Sex: F
Vaccine: HPV9, TDAP
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant and refers to a 23 years old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant medications were not reported. On 22-SEP-2017, the patient was vaccinated with an expired dose of GARDASIL 9 (dose not reported) (lot # L028083 and expiration date 03-SEP-2017) intramuscularly for prophylaxis. No adverse effects were reported.
Age: 63.0
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a registered pharmacist and refers to a 63 year old patient of unknown gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapy was not reported. On 29-JUL-2017, the patient was vaccinated with an improperly stored ZOSTAVAX, lot number M041087 with expiration date 03-JAN-2018 (dosage schedule, anatomical location and route of administration not provided) for prophylaxis, reconstituted with properly stored diluent (MRK INJ). The administered vaccine was exposed to a temperature of 6 degree Fahrenheit to 14 degree Fahrenheit for 1 hour. Previous temperature excursion was reported as 6 degree Fahrenheit to 14 degree Fahrenheit for 45 minutes. The call was because of a data logger. No adverse effects were reported. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1708USA010696: US-009507513-1708USA010732: US-009507513-1709USA014570: US-009507513-1709USA014571: US-009507513-1709USA014572: US-009507513-1709USA014574: US-009507513-1709USA014575: US-009507513-1709USA014576: US-009507513-1709USA014577: US-009507513-1709USA014569.
Age: 66.0
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a registered pharmacist and refers to a 66 year old patient of unknown gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapy was not reported. On 03-AUG-2017, the patient was vaccinated with an improperly stored ZOSTAVAX, lot number M041087 with expiration date 03-JAN-2018 (dosage schedule, anatomical location and route of administration not provided) for prophylaxis, reconstituted with properly stored diluent (MRK INJ). The administered vaccine was exposed to a temperature of 6 degree Fahrenheit to 14 degree Fahrenheit for 1 hour. Previous temperature excursion was reported as 6 degree Fahrenheit to 14 degree Fahrenheit for 45 minutes. The call was because of a data logger. No adverse effects were reported. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1708USA010696: US-009507513-1708USA010732: US-009507513-1709USA014569: US-009507513-1709USA014570: US-009507513-1709USA014571: US-009507513-1709USA014572: US-009507513-1709USA014573: US-009507513-1709USA014575: US-009507513-1709USA014576: US-009507513-1709USA014577.
Age: 69.0
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a registered pharmacist and refers to a 69 year old patient of unknown gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapy was not reported. On 03-AUG-2017, the patient was vaccinated with an improperly stored ZOSTAVAX, lot number M041087 with expiration date 03-JAN-2018 (dosage schedule, anatomical location and route of administration not provided) for prophylaxis, reconstituted with properly stored diluent (MRK INJ). The administered vaccine was exposed to a temperature of 6 degree Fahrenheit to 14 degree Fahrenheit for 1 hour. Previous temperature excursion was reported as 6 degree Fahrenheit to 14 degree Fahrenheit for 45 minutes. The call was because of a data logger. No adverse effects were reported. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1708USA010696: US-009507513-1708USA010732: US-009507513-1709USA014569: US-009507513-1709USA014570: US-009507513-1709USA014571: US-009507513-1709USA014572: US-009507513-1709USA014573: US-009507513-1709USA014574: US-009507513-1709USA014576: US-009507513-1709USA014577.
Age: 63.0
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a registered pharmacist and refers to a 63 year old patient of unknown gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapy was not reported. On 10-AUG-2017, the patient was vaccinated with an improperly stored ZOSTAVAX, lot number M041087 with expiration date 03-JAN-2018 (dosage schedule, anatomical location and route of administration not provided) for prophylaxis, reconstituted with properly stored diluent (MRK INJ). The administered vaccine was exposed to a temperature of 6 degree Fahrenheit to 14 degree Fahrenheit for 1 hour. Previous temperature excursion was reported as 6 degree Fahrenheit to 14 degree Fahrenheit for 45 minutes. The call was because of a data logger. No adverse effects were reported. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1708USA010696: US-009507513-1708USA010732: US-009507513-1709USA014569: US-009507513-1709USA014570: US-009507513-1709USA014571: US-009507513-1709USA014572: US-009507513-1709USA014573: US-009507513-1709USA014574: US-009507513-1709USA014575: US-009507513-1709USA014577.
Age: 60.0
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a registered pharmacist and refers to a 60 year old patient of unknown gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapy was not reported. On 11-AUG-2017, the patient was vaccinated with an improperly stored ZOSTAVAX, lot number M041087 with expiration date 03-JAN-2018 (dosage schedule, anatomical location and route of administration not provided) for prophylaxis, reconstituted with properly stored diluent (MRK INJ). The administered vaccine was exposed to a temperature of 6 degree Fahrenheit to 14 degree Fahrenheit for 1 hour. Previous temperature excursion was reported as 6 degree Fahrenheit to 14 degree Fahrenheit for 45 minutes. The call was because of a data logger. No adverse effects were reported. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1708USA010696: US-009507513-1708USA010732: US-009507513-1709USA014569: US-009507513-1709USA014570: US-009507513-1709USA014571: US-009507513-1709USA014572: US-009507513-1709USA014573: US-009507513-1709USA014574: US-009507513-1709USA014575: US-009507513-1709USA014576.
Sex: U
Vaccine: MMR
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a registered nurse, concerning multiple unspecified patients of an unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On an unspecified date, the patients were vaccinated with improperly stored doses M-M-R II with lot # M036544 and expiration date on 15-AUG-2018 (strength, dose, route of administration or anatomical location were not reported), reconstituted with an also improperly stored sterile diluent (manufacturer unknown) with lot # L025375 and expiration date on 14-MAR-2018; both administered for prophylaxis. The storage temperature was 9 to 25 degrees Celsius (°C) (9.8 °C), for a timeframe of 20 minutes and 9 to 25 °C (8.5 °C) for 7 minutes. There was previous temperature excursion at 9 to 25 °C for 3.31 hours. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA013515: US-009507513-1709USA015078.
Age: 70.0
Sex: M
Vaccine: FLU3
Symptoms: Contusion, Haemorrhage
Clinical narrative: Pt had had bleeding more than the average. Also had bruising. Other than that everything feels fine.
Age: 28.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Local reaction, Pruritus, Urticaria
Clinical narrative: Pt had a local reaction to vaccine (hives down the arm, itching and redness).
Age: 68.0
Sex: M
Vaccine: FLU3
Symptoms: Discomfort, Injection site bruising, Injection site pain
Clinical narrative: Excess bruising and pain at the injection site starting after receiving the injection, the patient noticed the brusing on monday after receiving the shot on saturday (roughly two days after the administration), bruising could have started earlier, but the patient didn't notice until then. The patient describes the pain and discomfort as a 3/10 on the pain scale.
Age: 36.0
Sex: M
Vaccine: PPV, TDAP
Symptoms: Bronchitis, Influenza virus test negative, Metabolic function test normal, Oropharyngeal pain, Pyrexia
Clinical narrative: Bronchitis, fever, sore throat.
Age: 36.0
Sex: M
Vaccine: PPV, TDAP
Symptoms: Sputum culture, Urine analysis normal, White blood cell count increased
Clinical narrative: Bronchitis, fever, sore throat.
Age: 79.0
Sex: M
Vaccine: FLU3
Symptoms: Anxiety, Seizure
Clinical narrative: Patient was about to receive vaccination, feeling anxious (per spouse), spouse wanted us to speed it up so he can get home. After receiving vaccination, about 5 minutes later, notified by spouse, had a seizure, told to call ambulance, intern/flu administrator called ambulance, during the call patient had another seizure.
Age: 64.0
Sex: F
Vaccine: FLU4
Symptoms: Blood pressure increased
Clinical narrative: PATIENT STATES THAT HER ELEVATED BLOOD PRESSURE BEGAN SOON AFTER SHE RECEIVED FLU VACCINE AT 2:00. SHE AND HER HUSBAND RETURNED HOME, BUT DECIDED TO GO TO THE ER AROUND 4 PM. BP WAS 237/100 AND WAS GIVEN HYDRALAZINE TO BRING IT DOWN. WHEN RELEASED HER BP WAS 176/92. SHE STATES THAT HER BP HAS STILL BEEN HIGHER THAN NORMAL.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Immunisation, Syringe issue
Clinical narrative: Injected patient with syringe and began to move the plunger. The plunger did not move or moved very little. I withdrew the needle from the patient and shielded the needle. I looked and saw that the full volume of the immunization was still in the syringe. The patient reported feeling a thud when injecting.  She did not report any other symptom or issue. The immunization was given again with a new needle and syringe.
Age: 62.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Injection site cellulitis
Clinical narrative: The patient developed cellulitis around the inject site. The patient was referred to her pcp or an urgent care to receive an antibiotic. The symptoms started appearing 12-24 hours post injection and continued to progress.
Age: 70.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Cellulitis, Pain, Swelling
Clinical narrative: The patient received immunizations then 12-24 hours later started having pain and swelling. Two days after the immunizations, he went to his doctor and was diagnosed with cellulitis. He was given an antibiotic to treat the infection.
Age: 73.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Pain, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: Patient called today 09/29/17 at about 3pm reporting that her arm was red, swollen and hot and it was very sore to move. Since she got both shots in the same arm i wasnt able to identify which shot was causing these symptoms. I told her to watch it and asked if she had checked her temp. She has not but says the arm feels hot. I told her that if it gets worse definitely call the dr or go to someone who can evaluate this for her. I called her back just now to get more info to fill this out and she said it was feeling better but still very sore. Thank you. I told her keep a close eye on it and I would call her sunday and check on her as thats the next day I work at this store.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site discolouration, Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: Patient reports a rash around injection site and tenderness to the touch. Originally was swollen and red, but has since improved. Patient still notes a small discoloration around injection site measuring approximately 2". Patient reports this 8 days post vaccination.
Age: 30.0
Sex: F
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient was vaccinated on 9/26/17. She noted soreness to right deltoid immediately after. She continued to feel soreness during the night. The next AM, 9/27/17 patient noted swelling and redness to deltoid area. She took some benedryl and iced the area for that day. On 9/28/17 patient called clinic complaining of swelling and redness. She stated that the area had increased in size from the day previous and she requested to be seen. Patient was given the next available appointment. Patient described the area of swelling as a circular patch of 3"x3" and approximately raised 2" above the arm. Patient was advised on how to treat this while at home and advised of then to seek emergent cares. Patient was seen the next AM at 10:00. The redness and swelling had reduced but was still visible. Patient advised to reconsider future flu vaccinations, to continue use of benedryl and ice until area is again comfortable.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: Skin discolouration, Urticaria
Clinical narrative: Hives developed to back, under both arms, torso and left arm covered in hives with purple discoloration. Went to ER and was administered Steroid shot and oral steroid s x 5 day and Benadryl .
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Arthralgia, Babesiosis, Chronic fatigue syndrome, Condition aggravated, Headache
Clinical narrative: Chronic headache, POTS, Babesiosis Lyme disease, Chronic fatigue syndrome, Joint pain.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Lyme disease, Postural orthostatic tachycardia syndrome
Clinical narrative: Chronic headache, POTS, Babesiosis Lyme disease, Chronic fatigue syndrome, Joint pain.
Age: 89.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Pt had injection site reaction on the left arm after administration of the above vaccines. Pt went to doctor and received antibiotic treatment but was not filled at our pharmacy. Pt complained about redness, swelling, and fever in the arm were vaccines were given.
Age: 42.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Paraesthesia oral, Pharyngeal paraesthesia, Rash
Clinical narrative: One week after having flu shot I started having a rash on lower right part of face (kind of like hives) also tingling and numbness of lips and cheek and a little bit of tickling/ tingling down into the right side of my throat. The tingling/numbness on my face started just below my lower lip on my chin on the right side yesterday (9/28/17) and has slowly spread out to my right cheek. There seems to be still a small rashy area on my chin just below my lower lip and some very slight swelling. I tried taking two generic Benadryl last night and also two this morning and it didn't seem to really help either time I took it.
Age: 42.0
Sex: F
Vaccine: FLU4
Symptoms: Swelling face
Clinical narrative: One week after having flu shot I started having a rash on lower right part of face (kind of like hives) also tingling and numbness of lips and cheek and a little bit of tickling/ tingling down into the right side of my throat. The tingling/numbness on my face started just below my lower lip on my chin on the right side yesterday (9/28/17) and has slowly spread out to my right cheek. There seems to be still a small rashy area on my chin just below my lower lip and some very slight swelling. I tried taking two generic Benadryl last night and also two this morning and it didn't seem to really help either time I took it.
Age: 53.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: The patient presented with redness, swelling, and pain on the arm of injection. Patient also received a flu shot in the same arm spaced out by 1 inch.
Age: 79.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site haemorrhage
Clinical narrative: Injection site looked hemorrhaged. The injection site was dark red whith what looked like blood underneath the skin. The patient did not experienced pain despited this.
Age: 12.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Pyrexia, Rash generalised
Clinical narrative: W/one day patient had a rash all over her body. Fever.
Age: 50.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: General symptom, Hypoaesthesia, Myelitis transverse, Nuclear magnetic resonance imaging spinal abnormal, Scan with contrast abnormal
Clinical narrative: About 30 days after the injection I started to have numbness below my waist along with other bizare symptoms. I woke up with numbness in my feet and it moved up to my waistline during the day.  04/12/15
Age: 9.0
Sex: M
Vaccine: FLU4
Symptoms: Cough, Dyspnoea, Hyperhidrosis, Rash, Urticaria
Clinical narrative: About 3 minutes after the vaccine was administered, patient started coughing and breaking out on his face with rash/hives, and complained of difficulty breathing. He also started to sweat on his forehead. Administered EPIPEN Jr on his right thigh through clothing. Called and ambulance and was transported to the ER.
Age: 83.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Peripheral swelling, Tenderness
Clinical narrative: Arm is red, swollen, and tender to touch.
Age: 67.0
Sex: M
Vaccine: FLU4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Vaccine used is recommended for adults less than 64 years old. Patient received vaccine is 67 years old.
Age: 63.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient returned to pharmacy on 9/29/17 complaining of redness, swelling, and pain at the injection site. The area of redness almost wrapped completely around her upper arm. Advised patient that it was most likely an injection site reaction and to take ibuprofen for the pain and BENADRYL for the reaction. I explained that if the redness worsened or if the area became more painful, swollen, red to follow up with her primary care physician.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Neck pain
Clinical narrative: Patient reported pain in left shoulder and neck about 12 hours after administration. Patient has contacted doctor and reported receiving one steroid shot and will be seen again.
Age: 30.0
Sex: M
Vaccine: FLU4, TDAP
Symptoms: Arthralgia, Neck pain, Pain, Pain in extremity
Clinical narrative: Per client's wife, patient reported shooting arm pain to neck and elbow which started within 3 hours following vaccination on 9/21/2017. This reaction was reported by client's wife to this RN on 09/25/2017. This RN recommended the client see his PCP on 09/25/2017 to have the symptoms evaluated. On 09/28/2017, the client's wife still reported patient to have pain which was shooting in nature to the neck and elbow. This RN asked if the client had been to a medical doctor to which the client's wife replied no. It was again recommended the client see a medical doctor to have his symptoms evaluated. On 09/29/2017, the health officer at Health Department was consulted regarding the client's symptoms by phone. The health officer concluded the client had possible brachial neuritis given the nature and length of the client's symptoms.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Fatigue, Feeling abnormal, Feeling hot, Pain
Clinical narrative: General not feeling right evening of injection. Morning after, entire body hurt/ached and felt extremely hot. No fever registered. In a mental haze all day and night. All symptoms lasted through the night. When I woke up the next morning, all symptoms were gone. Felt fine, just weak and worn out, like "the day after ".
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Induration, Local reaction, Swelling
Clinical narrative: Patient states she had a localized reaction, an approximately 2 inch by 2 inch area that was red and hardened and swollen.
Age: 38.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient reports that she had redness, swelling, and tenderness and injection site and the redness spread to an area on her shoulder large enough to promote concern. She went to the ER on Monday, Sept 25, 2017 where she was told it could be cellulitis and was prescribed Bactrim and Keflex.
Age: 69.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Arthralgia, Injection site erythema, Injection site swelling, Pain, Pain in extremity
Clinical narrative: Redness and swelling at lower injection site along with full body aches, joint pain, and inability to move arm without pain. This all occurred within 24 hours of receiving the vaccines. She was given azithromycin 250mg, ranitidine 150mg, and diphenhydramine 25mg.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HEP, PNC13, RV1
Symptoms: Pyrexia
Clinical narrative: Fever that started next morning (as with 2 month and 4 month shots). This fever has persisted for 4+ days and continues at a level of 102-103 when not on TYLENOL or ibuprofen.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site reaction, Injection site warmth
Clinical narrative: THE NIGHT OF THE VACCINES, MOM STATES THAT THE PATIENT'S L THIGH BEGAN TO HAVE A REACTION. PT SEEN IN OUR URGENT CARE CLINIC ON 9/28: Left anterior thigh: moderate erythema approximately 6cm x 4cm with mild warmth and minimal induration without fluctuance; non-tender.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: Rash at injection site. Approx. 3cm circular.
Age: 3.0
Sex: F
Vaccine: FLU4, HEPA, MMR, VARCEL
Symptoms: Blister, Decreased appetite, Erythema, Pain, Polymerase chain reaction positive
Clinical narrative: Did well in week immediately after vaccination. Sunday prior to office visit on 9/27/17 adoptive mom noticed she was not eating as well as usual and felt warm to touch. Did not measure fever. Over next few days slowly developing raised, initially papular lesions with underlying macular erythematous base. They became vesicles. Patient reports both painful and itchy. Lesions are sparsely scattered over right temporal region, torso, back, and upper and lower extremities. Should be noted child was directly exposed to active shingles lesions in the weeks prior to office visit on 9/14/17. Took shower with mom who was developing early shingles and did not know they were shingles.
Age: 3.0
Sex: F
Vaccine: FLU4, HEPA, MMR, VARCEL
Symptoms: Pruritus, Rash maculo-papular, Skin lesion, Skin warm, Varicella virus test positive
Clinical narrative: Did well in week immediately after vaccination. Sunday prior to office visit on 9/27/17 adoptive mom noticed she was not eating as well as usual and felt warm to touch. Did not measure fever. Over next few days slowly developing raised, initially papular lesions with underlying macular erythematous base. They became vesicles. Patient reports both painful and itchy. Lesions are sparsely scattered over right temporal region, torso, back, and upper and lower extremities. Should be noted child was directly exposed to active shingles lesions in the weeks prior to office visit on 9/14/17. Took shower with mom who was developing early shingles and did not know they were shingles.
Age: 65.0
Sex: F
Vaccine: PNC13, VARZOS
Symptoms: Injection site discolouration, Injection site reaction
Clinical narrative: 2 days after vaccines pt returned to pharmacy displaying redness at injection site, rx told her normal reaction to return to pharmacy if worsens. 4 days after vaccine, pt returned to pharmacy with increased area of redness at IM site, and dark Red, and black skin at subcutaneous site. Was told to return if worsens, or see MD.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Swelling
Clinical narrative: After 8 hr pt got injection, pt had an reaction of swelling. Pharmacist told pt that she needs to try BENADRYL and cortizone cream. On next day, pt came to ER and prescribed prednisone 20mg.
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Diplegia, Dizziness, Injection site swelling, Nausea, Peripheral swelling
Clinical narrative: PATIENT RECEIVED INJECTION AT 2PM SHE STATED TODAY ON CALL THAT BY 5:30PM SAME DATE AS VACCINATION SHE WAS NAUSEOUS VOMITING VERY DIZZY HAD SWELLING AT THE INJECTION SITE AND FELT PARALYZED IN HER ARMS - SHE WAS TRANSPORTED TO THE ER AND RECEIVED TREATMENT FOR HER ACUTE SYMPTOMS - SHE WAS INSTRUCTED TO ICE THE ARM - SHE STATED TODAY 9/29/17 THAT SHE WAS STILL FEELING THE ARM WAS SWOLLEN BUT THE OTHER SYMPTOMS HAVE SUBSIDED.
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Vomiting
Clinical narrative: PATIENT RECEIVED INJECTION AT 2PM SHE STATED TODAY ON CALL THAT BY 5:30PM SAME DATE AS VACCINATION SHE WAS NAUSEOUS VOMITING VERY DIZZY HAD SWELLING AT THE INJECTION SITE AND FELT PARALYZED IN HER ARMS - SHE WAS TRANSPORTED TO THE ER AND RECEIVED TREATMENT FOR HER ACUTE SYMPTOMS - SHE WAS INSTRUCTED TO ICE THE ARM - SHE STATED TODAY 9/29/17 THAT SHE WAS STILL FEELING THE ARM WAS SWOLLEN BUT THE OTHER SYMPTOMS HAVE SUBSIDED.
Age: 30.0
Sex: F
Vaccine: FLUC4
Symptoms: Diarrhoea, Fatigue, Headache, Injection site erythema, Injection site swelling
Clinical narrative: Redness, swelling, warm around injection site. Nausea, diarrhea, headache and fatigue.
Age: 30.0
Sex: F
Vaccine: FLUC4
Symptoms: Injection site warmth, Nausea
Clinical narrative: Redness, swelling, warm around injection site. Nausea, diarrhea, headache and fatigue.
Age: 80.0
Sex: F
Vaccine: PNC13
Symptoms: Impaired work ability, Injection site pain, Injection site swelling, Pain in extremity
Clinical narrative: Swelling and pain at and around injection site which then a small bump under the skin formed about 6 inches below injection site. She says the large amount of swelling did dissipate. However she claims of pain that extends from elbow to hand at times and pain near injection site when palpated enough to disturb her even during work which she works at a computer. Patient says on 09/26/2017 at doctor's visit the doctor recommended hot compress and acetaminophen. Patient used hot compress and found some relief but did not see value in acetaminophen but still has pain.
Age: 54.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Feeling abnormal, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Redness, swelling, pain that includes the whole arm, fever, and general not feeling good.
Age: 70.0
Sex: F
Vaccine: FLU3, PPV, FLU4, PPV
Symptoms: Asthenia, Chills, Muscular weakness
Clinical narrative: Severe chills, weak limbs, stroke-like weakness. Admitted to the hospital, stabilized. Discharged 9/29/17.
Age: 70.0
Sex: F
Vaccine: FLU3, PPV, FLU4, PPV
Symptoms: Asthenia, Chills, Computerised tomogram, Infection, Lethargy
Clinical narrative: Severe chills, weak limbs, stroke-like weakness. Admitted to the hospital, stabilized. Discharged 9/29/17.
Age: 70.0
Sex: F
Vaccine: FLU3, PPV, FLU4, PPV
Symptoms: Lumbar puncture, Motor dysfunction, Nuclear magnetic resonance imaging, Unresponsive to stimuli
Clinical narrative: Severe chills, weak limbs, stroke-like weakness. Admitted to the hospital, stabilized. Discharged 9/29/17.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site pain, Joint range of motion decreased
Clinical narrative: Severe L shoulder pain x 3 weeks with limited range of motion; presumed bursitis.
Age: 72.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Swelling, warm and redness on the site of injection. Soreness on the muscle area starting at 9 pm on Sept 25. Patient was advised to take NSAID and cold and warm compress alternatively. Today 09-29-2017 she said today the soreness and redness were gone.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Hypersensitivity, Rash, Rash pustular
Clinical narrative: Pt had a rash just above the elbow going halfway up the arm and 3/4 around the arm shortly after the shot. Pt also had pustules. Pt states she went to the doctor and was told she had an allergic reaction. They gave her a steroid patch.
Age: 83.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Patient caregiver came by the pharmacy and said the injection site (left arm) was a little red, itchy and sore. I told her to use a cold compress and take some MOTRIN or TYLENOL and use BENADRYL if it was itching. I told her that if it got worse to let us know and to call the doctor. I called tonight and the left arm was better. The patient went to the hospital to get it checked out. Everything is better now.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Urticaria
Clinical narrative: Patient called just before closing and said she had received her shingles vaccine at our pharmacy a few days ago. She said starting yesterday, a day after receiving the vaccine, that she had what she described as hives all over her body. She said that you couldn't see them but she could feel them all over and they itched. She said she was having no other symptoms. I instructed her to take BENADRYL for the itching and to keep an eye on it. Doctors offices are closed for the weekend but I told her if she starts having more severe symptoms (ex: difficulty breathing, etc) that she needs to get in and get checked out right away. We will also check back in with her and see how she is doing.
Age: 18.0
Sex: F
Vaccine: FLU4
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Patient came in on 9/29/17 w/Grandpa. She complained of itch. She had hives on legs and arm but not on injection site/ recommended BENADRYL and recommended to see her PCP.
Age: 76.0
Sex: F
Vaccine: FLU3
Symptoms: Asthma, Bronchospasm, Dyspnoea
Clinical narrative: Severe Breathing difficulty-at 1st thought was anaphylactic reaction. Less that 10min after shot gave shot EPI PEN (one) got better EMT came stayed 30min got better-seems more like Bronchospastic asthma episode.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Immediate post-injection reaction, Pruritus
Clinical narrative: Immediately after injection arm became red and itchy - I gave BENADRYL liquid PO and ice pack. Pt waited 15 min. Symptoms started to lesson. I called Pt. 4 hrs later. Still red and itching but not too bad.
Age: 52.0
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Erythema, Pain, Skin warm, Swelling
Clinical narrative: Soreness and pain, warm to touch, redness, swelling.
Age: 3.0
Sex: M
Vaccine: DTAP
Symptoms: Cough, Crying, Injection site erythema, Injection site induration, Injection site rash
Clinical narrative: Inconsolable crying greater than 3 hours after the vaccination. Cough noted. Rash at injection site - red and indurated, high fever.
Age: 3.0
Sex: M
Vaccine: DTAP
Symptoms: Pyrexia
Clinical narrative: Inconsolable crying greater than 3 hours after the vaccination. Cough noted. Rash at injection site - red and indurated, high fever.
Age: 62.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Swelling
Clinical narrative: Pt came back today 9/28/17 and showed redness around area, a little swelling.
Age: 61.0
Sex: M
Vaccine: FLU4
Symptoms: Chest pain, Headache, Myalgia
Clinical narrative: Chest pain - headache - muscle pain.
Age: 73.0
Sex: M
Vaccine: PNC13
Symptoms: Asthenia, Decreased appetite, Diarrhoea, Dizziness, Headache
Clinical narrative: Pt. said approx. 2:30 P 9/25/17 he started feeling ill with dizziness, fever, 102, HA and diarrhea. Everything but diarrhea and slight weakness remained 9/26/17. Pt. said keeping hydrated with fluids but not eating anything. 9/27/17 was when he 1st called. 9/28/17 no answer when called. 9/29/17 9:50 Pt. said he's back to normal.
Age: 73.0
Sex: M
Vaccine: PNC13
Symptoms: Malaise, Pyrexia
Clinical narrative: Pt. said approx. 2:30 P 9/25/17 he started feeling ill with dizziness, fever, 102, HA and diarrhea. Everything but diarrhea and slight weakness remained 9/26/17. Pt. said keeping hydrated with fluids but not eating anything. 9/27/17 was when he 1st called. 9/28/17 no answer when called. 9/29/17 9:50 Pt. said he's back to normal.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Red, swollen painful pneumo vac 23 reaction R bicep.
Age: 0.17
Sex: F
Vaccine: FLU4
Symptoms: Wrong drug administered
Clinical narrative: Patient came in for vaccine only. A PCV-13 should have been ordered and administered at the nurse visit. In error influenza vaccine FLULAVAL 0.5ml was ordered and administered to the 2month old.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Body temperature increased
Clinical narrative: Temp to 100.4 AM after imms. No other symptoms.
Age: 26.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: 30 minutes after vaccine (After valid Quad. Inactive) vaccine got - itching (L) hand, the redness (L) arm, then Rx IM and Oral steroids. B/L Arm and B/L Leg itching and hives low back.
Age: 21.0
Sex: F
Vaccine: FLUC4
Symptoms: Chest discomfort, Dizziness, Nausea, Paraesthesia oral, Pruritus
Clinical narrative: Dizziness, nausea, hives on arm (left) and chest that progressed over a few hours, tight chest, tingling lips, itchiness on face, back and stomach. Went to ER was given BENADRYL 50 mg and DECADRON. Itching stopped but returned next morning.
Age: 21.0
Sex: F
Vaccine: FLUC4
Symptoms: Urticaria
Clinical narrative: Dizziness, nausea, hives on arm (left) and chest that progressed over a few hours, tight chest, tingling lips, itchiness on face, back and stomach. Went to ER was given BENADRYL 50 mg and DECADRON. Itching stopped but returned next morning.
Age: 8.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Redness and firmness, warmth over 5-6 cm Lt deltoid. No systemic symptoms.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Pt. was having some redness, swollen, and itchy.
Age: 64.0
Sex: F
Vaccine: FLU4
Symptoms: Arthritis, Discomfort, Musculoskeletal pain, Pain in extremity
Clinical narrative: 24 hrs post Imz Pt complaining of discomfort. Arm/shoulder hurting went to ER clinic - they said the vaccine could have caused her rhem. arthritis to flare up.
Age: 77.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Chills, Peripheral swelling, Pyrexia
Clinical narrative: Swelling in upper arm, fevers, chills.
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Injection site pruritus, Injection site reaction, Injection site warmth, Rash erythematous, Skin reaction
Clinical narrative: Red rash, skin reaction, itchy, warm to touch. Was given Loratadine 10 mg tab 1 tab daily for 7 days (Both injection sites).
Age: 69.0
Sex: F
Vaccine: FLUC4, PPV
Symptoms: Erythema, Oedema, Vaccination complication
Clinical narrative: Patient with erythematous/edematous reaction to vaccines administered on 9/26/17. She denies decreased use of arm.
Age: 34.0
Sex: F
Vaccine: FLUR3
Symptoms: Dysphonia, Flushing, Hyperhidrosis, Hypopnoea, Skin warm
Clinical narrative: Warm, flushed, diaphoretic. Denies difficulty swallowing/breathing. Voice low, resp. shallow, no sensitivity to light reported. BP: 136/91, HR=45, pulse palpable.